Patent · US Expired

Interleukin-5 specific recombinant antibodies

USRE39548E1 · kind E1 · reissue

3Cited by
2References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 7, 2001
Grant dateApr 3, 2007
Priority date
Expiry dateDec 7, 2021

Classification

  • Technology area (CPC —)General

Abstract

An effective anti-IL-5 recombinant antibody molecule comprising heavy and/or light chain antigen-binding residues from a donor antibody.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.